Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedRecruitment status updated to indicate enrollment is closed. New help/navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment heading formatting was adjusted.SummaryDifference0.3%

- Check17 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a minor update to the page's version history without altering displayed content.SummaryDifference0.0%

- Check39 days agoChange DetectedPage revision tag updated to v3.5.4, replacing the previous v3.5.3. This indicates an updated version of the page content in the site's revision history.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Taiwan study site address changed from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333, updating the city designation in the location listing.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s footer revision/version label has been updated from **v3.5.2** to **v3.5.3**, indicating a site release or documentation version change rather than a change to the study content.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.